Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene

Hepatology

Volumn 24, Issue 5, 1996, Pages 1264-1268

  Xu, Guo Wei ^a   Sun, Zong Tang ^b   Forrester, Kathleen ^a   Wang, Xin Wei ^a   Coursen, Jill ^a   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS VECTOR;

ARTICLE; CARCINOMA CELL; CHEMOSENSITIVITY; CLONAL ANERGY; CYTOTOXICITY; DNA FLANKING REGION; GENE TRANSFER; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RETROVIRUS; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION;

EID: 0001642806     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008903408     Document Type: Article

References (30)

1. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350:427-428.
2. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350: 429-431.
3. Scorsone KA, Zhou YZ, Butel JS, Slagle BL. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 1992;52:1635-1638.
4. Li D, Cao Y, He L, Wang NJ, Gu JR. Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis 1993;14:169-173.
5. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
6. Aguilar F, Harris CC, Sun T, Hollstein M, Cerutti P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science 1994;264: 1317-1319.
7. Aguilar F, Hussain SP, Cerutti P. Aflatoxin Bl induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci U S A 1993;90:8586-8590.
8. Harris CC. Structure and function of the tumor suppressor gene: clues for rational cancer therapeutic strategies. J Nat Canc Inst, in press.
9. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967.
10. Huber BE, Richards CA, Krenitsky TA. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci U S A 1991;88:8039-8043.
11. Macri P, Gordon JW. Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir. Hum Gene Ther 1994;5:175-182.
12. Watanabe K, Saito A, Tamaoki T. Cell-specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene. J Biol Chem 1987; 262:4812-4818.
13. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249:912-915.
14. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 1992;256:827-830.
15. Morgenstern J, Land H. Choice and manipulation of retroviral vectors. In: Murray EJ, ed. Methods in molecular biology. Clifton, NJ: Humana, 1991: 181-202.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual. Vol II. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
17. Wang NP, To H, Lee WH, Lee EY. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells. Oncogene 1993;8:279-288.
18. Wang XW, Vermeulen W, Coursen JD, Gibson M, Lupold SE, Forrester K, Xu G, et al. The XPB and XPD helicases are components of the p53-mediated apoptosis pathway. Genes Dev 1996;10:1219-1232.
19. Gilboa E. Retrovirus vectors and their uses in molecular biology. Bioessays 1986;5:252-257.
20. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA. Induction of chemosensitivity in human lung cancer cells in vivo by adenovir us-mediated transfer of the wild-type p53 gene. Cancer Res 1994;54:2287-2291.
21. Friedmann T. Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer 1992;70:1810-1817.
22. Zhang WW, Fang X, Mazur W, French BA, Georges, RN, Roth JA. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1994;1:5-13.
23. Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 1994;54: 3662-3667.
24. Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 1995;55:1-6.
25. Fujiwara T, Grimm EA, Mukhopadhyay T, Cai DW, Owen-Schaub LB, Roth JA. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res 1993;53:4129-4133.
26. Bacchetti S, Graham F. Inhibition of cell proliferation by an adenovirus vector expressing the human wild-type p53 protein. Int J Oncol 1993;3: 781-788.
27. Sakai M, Morinaga T, Urano Y, Watanabe K, Wegmann TG, Tamaoki T. The human alpha-fetoprotein gene. Sequence organization and the 5′ flanking region. J Biol Chem 1985;260:5055-5060.
28. Sun T, Yu H, Hsai C, Wang N, Huang X. Evaluation of sera-survey trials for the early detection of hepatocellular carcinoma in areas of high prevalence. In: Chamberlain J, Miller AB, eds. Screening for Gastrointestinal Cancer. Toronto, Lewiston, NY: Huber, 1988:81-86.
29. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992;256:1550-1552.
30. Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 1993;14:987-992.